Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have fundamentally challenged the…
Read More
Oregon State University Researchers Develop Breakthrough Sugar-Coated Nanoparticle Delivery System to Combat Glioblastoma Brain Cancer
In a significant advancement for neuro-oncology, a research team at the Oregon State University College of Pharmacy has unveiled a…
Read More
Glioblastoma Research Reveals Skull Erosion and Immune System Reprogramming Reshaping Treatment Strategies
The medical community has long viewed glioblastoma multiforme (GBM) as a localized, albeit highly aggressive, malignancy confined within the blood-brain…
Read More
Regional Bone Marrow Niches in the Skull Identified as Critical Defense Hubs Against Aggressive Glioblastoma Tumors
Glioblastomas represent one of the most formidable challenges in modern oncology, remaining largely incurable despite decades of intensive research. These…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More
Glioblastoma Research Reveals Cancer Reshapes Skull Bone and Disrupts Systemic Immune Response to Fuel Tumor Growth
The traditional understanding of glioblastoma multiforme (GBM) as a localized malignancy confined within the blood-brain barrier is being fundamentally challenged…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – In a significant development offering renewed hope in the challenging landscape of brain cancer treatment, researchers…
Read More
Localized Immune Reservoirs in the Skull Offer New Hope for Glioblastoma Treatment While Challenging Conventional Surgical Approaches
In a discovery that challenges decades of immunological dogma, researchers from the German Cancer Consortium (DKTK) at the West German…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
In a significant stride forward against one of the most formidable and lethal human cancers, researchers at UCLA have successfully…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Researchers at UCLA have achieved a significant milestone in the arduous fight against glioblastoma, a notoriously aggressive and lethal form…
Read MoreYOU MAY HAVE MISSED
